Loading MGX charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading MGX comparable companies…
| MGXMetagenomi Therapeutics, Inc.(opens in a new tab) | $0.03B | $0.02B | −50.7% | — | — | — | — |
|---|---|---|---|---|---|---|---|
| LENZLENZ Therapeutics, Inc.(opens in a new tab) | $0.10B | — | — | — | — | — | — |
| GLUEMonte Rosa Therapeutics, Inc.(opens in a new tab) | $1.09B | $0.03B | −83.9% | — | −633.0% | 37.94× | — |
| XFORX4 Pharmaceuticals, Inc(opens in a new tab) | $0.42B | $0.02B | −51.6% | 81.5% | −554.7% | 26.75× | 167.8× |
| SCLXScilex Holding Co(opens in a new tab) | $0.01B | $0.03B | −28.5% | 161.1% | −1136.4% | 0.42× | — |
| Medianpeers, excl. MGX | $0.26B | $0.03B | −51.6% | 121.3% | −633.0% | 26.75× | 167.8× |